Michele Guida

5.9k citations
146 papers · 3.2k · h-index 28

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cutaneous Melanoma Detection and Management
    • Vascular Tumors and Angiosarcomas
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Cancer Immunotherapy and Biomarkers 27
    • Cutaneous Melanoma Detection and Management 24
    • CAR-T cell therapy research 16
    • Lung Cancer Research Studies 7
    • Melanoma and MAPK Pathways 38

Michele Guida

141 papers receiving 3.2k citations

Peers

Michele Guida
Comparison fields: 5 of 108
  • Oncology 1.8k
  • Immunology 721
  • Cancer Research 288
  • Pulmonary and Respiratory Medicine 535
  • Ophthalmology 124
Replace Luis de la Cruz‐Merino with:
Luis de la Cruz‐Merino Spain
Lev Demidov Russia
Leslie A. Fecher United States
Iván Márquez‐Rodas Spain
Taher Al‐Tweigeri Saudi Arabia
Oddbjørn Straume Norway
Geoffrey T. Gibney United States
Amaya Virós United Kingdom
José A. López-Martín Spain
Ronan J. Kelly United States
Michele Guida relative to Luis de la Cruz‐Merino Spain Luis de la Cruz‐Merino's profile →
Citations per field
00.5×1.5×
Luis de la Cruz‐Merino · 1×
Citations per year

Countries citing papers authored by Michele Guida

Since Specialization
Citations

This map shows the geographic impact of Michele Guida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Guida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Guida more than expected).

Fields of papers citing papers by Michele Guida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Guida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Guida. The network helps show where Michele Guida may publish in the future.

Co-authors

The 25 scholars most cited alongside Michele Guida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michele Guida Line = papers co-authored together Michele Guida links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011444
2 2001151
3 2016140
4 2014128
5 2022122
6 2013110
7 201498
8 200595
9 201488
10 201684
11 201477
12 200454
13 200254
14 201547
15 201144
16 202143
17 202140
18 201539
19 202137
20 201533

About Michele Guida

Michele Guida is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Organic Chemistry, having authored 146 papers that have together received 3.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (38 papers), Cancer Immunotherapy and Biomarkers (27 papers), Cutaneous Melanoma Detection and Management (24 papers), CAR-T cell therapy research (16 papers), Immunotherapy and Immune Responses (14 papers), Click Chemistry and Applications (8 papers), Computational Drug Discovery Methods (8 papers) and Lung Cancer Research Studies (7 papers). The work is most often cited by research in Oncology (1.8k citations), Immunology (721 citations), Cancer Research (288 citations), Pulmonary and Respiratory Medicine (535 citations) and Ophthalmology (124 citations). Michele Guida has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Sabino Strippoli, Vanna Chiarion‐Sileni, Laura Ridolfi, Amalia Azzariti, Paolo A. Ascierto, Letizia Porcelli, Paola Queirolo, Johan Hansson, Scott D. Chasalow and Omid Hamid. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Translational Medicine, International Journal of Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact